Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
Clinical trial NCT04099251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04099251
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2022-06-28
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.